Ambit Biosciences Obtains $50,000,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e3a73982-ccd0-46f7-b6ef-3c77932cace8&Preview=1 -
Date
11/6/2012 -
Company Name
Ambit Biosciences -
Mailing Address
4215 Sorrento Valley Blvd. San Diego, CA 92121 -
Company Description
Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer. -
Website
http://www.ambitbio.com -
Transaction Type
Venture Equity -
Transaction Amount
$50,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
This financing, with OrbiMed Advisors leading a round in which all existing investors participated, is a strong vote of confidence in our direction and provides the resources to accelerate our progress in 2013. -
M&A Terms
-
Venture Investor
OrbiMed Advisors -
Venture Investor
Aisling Capital -
Venture Investor
Roche Venture Fund -
Venture Investor
MedImmune Ventures -
Venture Investor
Forward Ventures -
Venture Investor
Growthworks Capital -
Venture Investor
GIMV -
Venture Investor
Radius Ventures
